ONCOS-102 and Immunotherapy for Mesothelioma: Podcast Explains Benefits of the Pairing
By: Devin Golden
September 20, 2020
Update: This podcast was recorded in September, one month before the FDA approved nivolumab and ipilimumab for pleural mesothelioma. This news altered the plans for a lot of...
Read Post